|
P4HA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.6292999999965E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.94560000000333E-05 |
| Normal-vs-Stage2 |
2.863200E-01 |
| Normal-vs-Stage3 |
1.238420E-02 |
| Normal-vs-Stage4 |
5.648200E-04 |
| Stage1-vs-Stage2 |
1.217370E-01 |
| Stage1-vs-Stage3 |
4.075200E-01 |
| Stage1-vs-Stage4 |
6.862400E-02 |
| Stage2-vs-Stage3 |
4.079400E-01 |
| Stage2-vs-Stage4 |
1.357770E-02 |
| Stage3-vs-Stage4 |
3.448000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.246990E-04 |
| Normal-vs-AfricanAmerican |
5.650000E-04 |
| Normal-vs-Asian |
4.762400E-03 |
| Caucasian-vs-AfricanAmerican |
3.438300E-02 |
| Caucasian-vs-Asian |
8.453000E-01 |
| AfricanAmerican-vs-Asian |
6.783800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.117800E-03 |
| Normal-vs-Female |
4.36820000000449E-05 |
| Male-vs-Female |
8.991000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.29439999999137E-05 |
| Normal-vs-Age(41-60Yrs) |
2.480000E-03 |
| Normal-vs-Age(61-80Yrs) |
7.376100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.475030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.410800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.665000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.742600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.374200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.006400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.188200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.504020E-03 |
| Classical-VS-Follicular |
5.013400E-01 |
| Classical-VS-Other |
2.925200E-01 |
| Classical-VS-Normal |
1.04580000004351E-06 |
| Tall-VS-Follicular |
7.420200E-02 |
| Tall-VS-Other |
7.553600E-01 |
| Tall-VS-Normal |
7.075000E-01 |
| Follicular-VS-Other |
6.122000E-01 |
| Follicular-VS-Normal |
2.003800E-02 |
| Other-VS-Normal |
5.588400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.538300E-03 |
| Normal-vs-N1 |
5.496200E-02 |
| N0-vs-N1 |
9.708400E-01 |
|
|
